Utilization of Low Dose Depakote for the Treatment of Delirium in Hospitalized Adults: A Retrospective Analysis of Depakote Treatment Protocol

Authors

  • Brandon Scott McCrobie Duke University School of Nursing, North Carolina, USA Author
  • Anne Derouin Duke University School of Nursing, North Carolina, USA Author
  • Manjula Krishnamurthy Duke University School of Nursing, North Carolina, USA Author
  • Abhijai Singh Duke University School of Nursing, North Carolina, USA Author

Abstract

Objective: The primary aim of this study was to evaluate the safety and efficacy of a low-dose Depakote protocol for the treat
ment of delirium in hospitalized adult patients.Methods: Participants were selected through a retrospective chart review for 24 months pre- and post- intervention. Demographic variables were compared using univariate statistics. The primary outcome was patient’s length of stay (LOS), compared using a Mann-Whitney-U test. The three other outcomes of antipsychotic administration, benzodiazepine administration, and incidence of injury were measured using separate Fisher’s exact tests. Mann Whitney-U tests were conducted to compare antipsychotic and benzodiazepine dose administration using haloperidol and lorazepam equivalents. Incidence and severity of adverse effects were analyzed using descriptive statistics for patients administered the Depakote protocol. IBM SPSS version 27 was used to conduct the statistical analysis with αset to .05. Results: The retrospective analysis evaluated 102 patient records. There were no significant differences in age, sex, or admission diagnosis classification. The hospital length of stay showed no statistically significant difference between-groups (median non-Depakote 7.5, median Depakote 7.0, z= -.188, p= .881). However, there was a difference in antipsychotic medication usage between two groups. Antipsychotic use was measured in haloperidol equivalents, while benzodiazepine use was measured in lorazepam equivalents. Antipsychotic utilization decreased significantly from 92.3% (non-Depakote group) to 42% (Depakote group) (p<.001). Similarly, benzodiazepine utilization also decreased significantly from 57.7% (non-Depakote group) to 6% (Depakote group) (p<.001). Median total antipsychotic dosage also decreased significantly from 14.5mg (non-Depakote group) 

References

Kalish, V. B., Gillham, J. E., Unwin, B. K. (2014) Delirium in older persons: evaluation and management. Am Fam Physician, 90(3): 150-158.

Maldonado, J. R. (2014) Delirium-In Gabbard's treatments of psychiatric disorders, 5th ed. (pp. 947-956). American Psychiatric Publishing, 5: 947-956.

Dasgupta, M., Brymer, C. (2014) Prognosis of Delirium in hospitalized elderly: worse than we thought. Int J Geriatr Psychiatry, 29(5): 497-505. https://doi.org/10.1002/gps.4032

Sher, Y., Cramer, A. C. M., Ament, A., Lolak, S., Maldonado, J. R. (2015) Valproic acid for treatment of hyperactive or mixed Delirium: Rationale and literature review. Psychosomatics, 56(6): 615-625. https://doi.org/10.1016/j. psym.2015.09.008.

Rose, L., Burry, L., Agar, M., Campbell, N. L., Clarke, M., Lee, J., et al. (2021) A Core Outcome Set for Research Evaluating Interventions to Prevent and/or Treat Delirium in Critically Ill Adults: An International Consensus Study (Del-COrS). Critical care medicine. Crit Care Med, 49(9): 1535-1546. https://doi-org.proxy.lib.duke.edu/10.1097/ CCM.0000000000005028.

Serafim, R. B., Bozza, F. A., Soares, M., do Brasil, P. E., Tura, B. R., Ely, E. W., et al. (2015) Pharmacologic prevention and treatment of delirium in intensive care patients: A systematic review. J Crit Care, 30(4): 799-807. https:// doi.org/10.1016/j.jcrc.2015.04.005.

Gagnon, D. J., Fontaine, G. V., Smith, K. E., Riker, R. R., Miller, R. R., 3rd, Lerwick, P. A., et al. (2017) Valproate for agitation in critically ill patients: A retrospective study. J Crit Care, 37: 119-125. https://doi.org/10.1016/j. jcrc.2016.09.006.

Crowley, K. E., Urben, L., Hacobian, G., Geiger, K. L. (2020) Valproic Acid for the Management of Agitation and Delirium in the Intensive Care Setting: A Retrospective Analysis. Clin Ther, 42(4): e65-e73. https://doi.org/10.1016/j. clinthera.2020.02.007.

Sher, Y., Miller, A. C., Lolak, S., Ament, A., Maldonado, J. R. (2015) Adjunctive Valproic Acid in Management-Refractory Hyperactive Delirium: A Case Series and Rationale. J Neuropsychiatry Clin Neurosci, 27(4): 365-370. https:// doi.org/10.1176/appi.neuropsych.14080190.

Horiguchi, J., Yamashita, H., Yanai, I., Katagiri, H., Miyoshi, I., Yokota, N., et al. (1998) Effectiveness of Valproate on Delirium and/or Aggressive Behavior in Demented Patients: A practical pilot study. Int J Psychiatry Clin Pract, 2(1): 35- 39. https://doi.org/10.3109/13651509809115112.

Gagnon, D. J., Fontaine, G. V., Riker, R. R., Fraser, G. L. (2017) Repurposing Valproate, Enteral Clonidine, and Phenobarbital for Comfort in Adult ICU Patients: A Literature Review with Practical Considerations. Pharmacotherapy, 37(10): 1309-1321. https://doi.org/10.1002/phar.2017.

Downloads

Published

2021-09-10